» Articles » PMID: 30634516

Relationships Between Vitamin D₃ and Metabolic Syndrome

Overview
Publisher MDPI
Date 2019 Jan 13
PMID 30634516
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The growing number of overweight and obese individuals is an alarming global problem; these conditions are risk factors for the development of health problems such as metabolic syndrome (MetS), type-2 diabetes, atherosclerosis, and cardiovascular disease. Numerous studies have suggested that vitamin D₃ deficiency plays a role in the pathogenesis of MetS. The aim of this study was to analyze the relationship between MetS and vitamin D₃ levels in women. Laboratory analysis demonstrated that only 26.89% of the participants had vitamin D₃ levels close to normal, and waist-to-hip ratio (WHR) measurements revealed android obesity in 75.63% of the women. The menstruating women more often suffered from vitamin D₃ deficiency, and less often had elevated vitamin D₃ levels. The conclusions are as follows: (1) There were no statistically significant relationships between vitamin D₃ levels and MetS parameters, namely the level of triglycerides, the levels of low- and high-density lipoproteins (LDL and HDL), the level of total cholesterol, and systolic and diastolic blood pressure (SBP and DBP). Vitamin D deficiency was only observed in the women with abdominal obesity. (2) Low vitamin D₃ levels were typical of perimenopausal women. Age was a variable correlating with vitamin D. (3) The presence of menstrual cycles was an important contributor to vitamin D levels. Vitamin D deficiency was significantly more common in the menstruating women.

Citing Articles

Vitamin D status and prevalence of metabolic syndrome by race and Hispanic origin in US adults: findings from the 2007-2014 NHANES.

Ahluwalia N, Raghavan R, Zhang G, Talegawkar S, Jacques P Am J Clin Nutr. 2022; 116(5):1400-1408.

PMID: 36036472 PMC: 10474946. DOI: 10.1093/ajcn/nqac234.


The effect of iron dextran on vitamin D metabolism in SD rats.

Qiu F, Li R, Gu S, Zhao Y, Yang L Nutr Metab (Lond). 2022; 19(1):47.

PMID: 35842653 PMC: 9288701. DOI: 10.1186/s12986-022-00681-5.


Prevalence and Prognostic Significance of Malnutrition in Hypertensive Patients in a Community Setting.

Yang Z, Wei X, Fu B, Chen J, Yu D Front Nutr. 2022; 9:822376.

PMID: 35284455 PMC: 8905503. DOI: 10.3389/fnut.2022.822376.


Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies.

Innao V, Allegra A, Ginaldi L, Pioggia G, De Martinis M, Musolino C Int J Mol Sci. 2021; 22(9).

PMID: 34066482 PMC: 8124934. DOI: 10.3390/ijms22094922.


The association between nutrient patterns and metabolic syndrome among Iranian adults: cross-sectional analysis of Shahedieh cohort study.

Sadeghi O, Sadeghi A, Mozaffari-Khosravi H, Shokri A Public Health Nutr. 2020; 24(11):3379-3388.

PMID: 32641199 PMC: 10195254. DOI: 10.1017/S1368980020001639.


References
1.
Gulseth H, Gjelstad I, Birkeland K, Drevon C . Vitamin D and the metabolic syndrome. Curr Vasc Pharmacol. 2013; 11(6):968-84. DOI: 10.2174/15701611113119990169. View

2.
Ronti T, Lupattelli G, Mannarino E . The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf). 2006; 64(4):355-65. DOI: 10.1111/j.1365-2265.2006.02474.x. View

3.
Dos Reis G, Gontijo N, Rodrigues K, Alves M, Ferreira C, Gomes K . Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review. J Obstet Gynaecol Res. 2017; 43(3):436-446. DOI: 10.1111/jog.13250. View

4.
Autier P, Gandini S . Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med. 2007; 167(16):1730-7. DOI: 10.1001/archinte.167.16.1730. View

5.
Goldner W, Stoner J, Thompson J, Taylor K, Larson L, Erickson J . Prevalence of vitamin D insufficiency and deficiency in morbidly obese patients: a comparison with non-obese controls. Obes Surg. 2008; 18(2):145-50. DOI: 10.1007/s11695-007-9315-8. View